The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Results of a Study Examining Nivolumab in Metastatic Bladder Cancer

Matthew Galsky, MD
Published Online:2:50 PM, Mon February 13, 2017

Matthew Galsky, MD, professor of Medicine at the Mount Sinai School of Medicine, discusses results of a study examining nivolumab monotherapy in metastatic bladder cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.